Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2018

Nov 6, 2018

29871_dirs_2018-11-06_9750c4eb-7b85-4252-a870-a4d31bdd14fc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2018-11-02

Reporting Person: Spencer Michael A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-11-02 Common Stock Class A A 3020690 Acquired 3020690 Direct

Footnotes

F1: Received in exchange for shares of NEX Group plc ("NEX") in connection with the acquisition (the "Acquisition") of NEX by CME Group Inc. Pursuant to the terms of Acquisition, NEX shareholders received for each NEX Group ordinary share 500 pence in cash and 0.0444 shares of CME Group Class A common stock. The effective date of the Acquisition was November 2, 2018. The closing price on the trading day prior to the effective date of the Acquisition was $183.75 for CME Group Class A common stock. Immediately prior to the effective date of the Acquisition and the exchange of shares, Mr. Spencer held 68,033,572 shares of NEX.